{"transactions":[{"id":749264,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-04T20:05:23.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":2.19,"value":3863.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":8938,"derivative":{"exercise_price":2.19,"exercise_date":"2027-06-03","expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-26-027261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315226027261/ownership.xml","form_type":"4"}},{"id":1120953,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:06:49.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":3.2,"value":5644.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":7174,"derivative":{"exercise_price":3.2,"exercise_date":"2026-06-04","expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001641172-25-013795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000164117225013795/ownership.xml","form_type":"4"}},{"id":1486206,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T21:43:25.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1764,"price":7.05,"value":12436.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":5410,"derivative":{"exercise_price":7.05,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1764},"source":{"system":"sec-edgar","filing":"0001493152-24-023211","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315224023211/ownership.xml","form_type":"4"}},{"id":1894728,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-12T20:34:28.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0.2656,"value":7968.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant."}],"balance_after":62000,"derivative":{"exercise_price":0.2656,"exercise_date":"2024-05-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-23-016685","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315223016685/ownership.xml","form_type":"4"}},{"id":2235474,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T15:32:47.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":22000,"price":0.92,"value":20240.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1)\t100% vesting one year from date of grant."}],"balance_after":32000,"derivative":{"exercise_price":0.92,"exercise_date":"2023-06-08","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001493152-22-016399","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222016399/ownership.xml","form_type":"4"}},{"id":2298226,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T20:57:54.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":10000,"price":1.16,"value":11600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of April 11, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years."}],"balance_after":10000,"derivative":{"exercise_price":1.16,"exercise_date":"2023-04-11","expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-009716","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000149315222009716/ownership.xml","form_type":"4"}},{"id":3181074,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Business Development"}}],"security":"Common stock","published_at":"2020-04-07T12:46:58.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":194805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control."}],"balance_after":194805,"source":{"system":"sec-edgar","filing":"0000882104-20-000045","document":"wf-form4a_158626360070465.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210420000045/wf-form4a_158626360070465.xml","form_type":"4/A","original_submission_date":"2020-01-08"}},{"id":3313927,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Business Development"}}],"security":"Common stock","published_at":"2020-01-10T23:36:01.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":194805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest as follows: (a) 40% of the shares subject to the award shall vest on the one year anniversary of the grant date and (b) 2.5% of the shares subject to the award shall vest monthly thereafter; provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance and retention plans covering the participant."}],"balance_after":194805,"source":{"system":"sec-edgar","filing":"0000882104-20-000005","document":"wf-form4_157869934395847.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210420000005/wf-form4_157869934395847.xml","form_type":"4"}},{"id":3555358,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-16T21:18:01.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":384615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The number of shares included in the original April 1, 2019 Form 4 filing was incorrect and the Company is filing this amendment to correct the number of shares in the award grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient."}],"balance_after":384615,"derivative":{"exercise_price":3.72,"expiration_date":"2029-03-28","underlying":"Common stock","underlying_shares":384615},"source":{"system":"sec-edgar","filing":"0000882104-19-000041","document":"wf-form4a_155544946729502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000041/wf-form4a_155544946729502.xml","form_type":"4/A","original_submission_date":"2019-04-01"}},{"id":3573075,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-01T21:12:58.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":377358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient."}],"balance_after":377358,"derivative":{"exercise_price":3.72,"expiration_date":"2029-03-28","underlying":"Common stock","underlying_shares":377358},"source":{"system":"sec-edgar","filing":"0000882104-19-000026","document":"wf-form4_155415316311719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000026/wf-form4_155415316311719.xml","form_type":"4"}},{"id":3806869,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":41248,"kind":"person","name":"Jene Jill M.","position":1,"cik":"0001742105","reported_name":"Jene Jill M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Business Development"}}],"security":"Stock Option (right to buy)","published_at":"2018-09-27T20:40:05.000Z","date":"2018-09-25","kind":"grant","acquired":true,"shares":377358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest on a monthly basis pro rata over the 48 months following January 1, 2018, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient."}],"balance_after":377358,"derivative":{"exercise_price":2.52,"expiration_date":"2028-09-25","underlying":"Common stock","underlying_shares":377358},"source":{"system":"sec-edgar","filing":"0000882104-18-000102","document":"wf-form4_153808078828040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000102/wf-form4_153808078828040.xml","form_type":"4"}}]}